| Cat.No. |
Chemical Name |
MolFormula |
| HR468738 |
Pf-4989216 |
C18H13FN6OS |
| HR468720 |
PGD2-inhibitor |
C23H23Cl2N3O3 |
| HR468703 |
Prinomastat |
C18H21N3O5S2 |
| HR468702 |
Pd151746 |
C11H8FNO2S |
| HR468657 |
Phenyl (5-chloro-4-methylthiazol-2-yl)carbamate |
C11H9ClN2O2S |
| HR468634 |
Polyketomycin |
C44H48O18 |
| HR468610 |
Pactamycin |
C28H38N4O8 |
| HR468580 |
Perfluorophenyl 3-(2-(2-(4-formylbenzamido)ethoxy)ethoxy)propanoate |
C21H18F5NO6 |
| HR468567 |
Pa 452 |
C26H37N3O3 |
| HR468547 |
PBD-BODIPY |
C21H19BF2N2 |
| HR468525 |
PROTAC ERRα Degrader-1 |
C54H49Cl2F6N7O8 |
| HR468493 |
Phen-dc3 |
C34H26N6O2 |
| HR468399 |
Perfluorophenyl 15-(2,5-Dioxo-2H-Pyrrol-1(5H)-Yl)-13-Oxo-3,6,9-Trioxa-12-Azapentadecan-1-Oate |
C21H21F5N2O8 |
| HR468397 |
PG 01 |
C28H29N3O2 |
| HR468124 |
Phenyl(quinolin-3-yl)methanone |
C16H11NO |
| HR468036 |
PSEUDOLARIC ACID C |
C21H26O7 |
| HR467001 |
Phenyl(thiazol-2-yl)methanol |
C10H9NOS |
| HR466783 |
Phenyl 6-methylquinoline-8-carboxylate |
C17H13NO2 |
| HR466519 |
Phenyl 7-methylquinoline-8-carboxylate |
C17H13NO2 |
| HR465362 |
PKM2 inhibitor(compound 3k) |
C18H19NO2S2 |
| HR465123 |
Phenyl(2-(quinolin-6-yl)pyrrolidin-1-yl)methanone |
C20H18N2O |
| HR464962 |
Pyrrolidin-3-ylmethyl cyclobutanecarboxylate hydrochloride |
C10H18ClNO2 |
| HR464939 |
Pyrrolidin-1-yl(5,6,7,8-tetrahydroimidazo[1,2-a]pyrazin-8-yl)methanone |
C11H16N4O |
| HR464690 |
Pyrrolidin-1-yl(4-(trifluoromethyl)phenyl)methanone |
C12H12F3NO |
| HR464522 |
Pyrrolidin-1-yl(pyrrolidin-3-yl)methanone hydrochloride |
C9H17ClN2O |
| HR464517 |
Phenyl(2-(thiophen-3-yl)pyrrolidin-1-yl)methanone |
C15H15NOS |
| HR464205 |
Pyrrolidin-3-ylmethyl cyclopropanecarboxylate hydrochloride |
C9H16ClNO2 |
| HR464204 |
Pyrrolidin-3-yl 3-methylbutanoate hydrochloride |
C9H18ClNO2 |
| HR464203 |
Pyrrolidin-3-yl 2-chloroacetate hydrochloride |
C6H11Cl2NO2 |
| HR464198 |
Pyrrolidin-3-yl cyclobutanecarboxylate hydrochloride |
C9H16ClNO2 |
